Results 241 to 250 of about 645,855 (340)

Clinical progress note: Rubella

open access: yesJournal of Hospital Medicine, EarlyView.
Abstract Rates of rubella infection and congenital rubella syndrome decreased significantly since the introduction of the rubella vaccine in 1969. Endemic rubella was declared eliminated in the United States in 2004, and since 2012, all rubella cases in the United States have been associated with infections acquired abroad.
Adam E. Gailani   +2 more
wiley   +1 more source

Innovative and sustainable solutions for reducing 'zero-dose' vaccination: How can the region respond? [PDF]

open access: yesFront Public Health
Abdel Majeed Z   +12 more
europepmc   +1 more source

Clinical progress note: Hepatitis A virus

open access: yesJournal of Hospital Medicine, EarlyView.
Abstract Despite a decline in hepatitis A virus (HAV) incidence following vaccine introduction, HAV remains a public health concern in the United States. Recent multi‐state outbreaks have demonstrated that HAV can re‐emerge and highlight inequities in vaccine coverage or access, outbreak response, and in those with social or health risk factors ...
James M. McCluskey III   +2 more
wiley   +1 more source

Immunological effects of alpha‐lactalbumin‐enriched low‐protein infant formula: A randomized controlled trial

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Breast‐fed (BF) have lower risk of infections during infancy compared to those formula‐fed (FF). A higher content of alpha‐lactalbumin (α‐lac) in breast milk, which may promote a more favorable gut microbiota, could be one reason.
Ulrika T. Nilsson   +7 more
wiley   +1 more source

Health economics and vaccine financing in the eastern Mediterranean region: A needs assessment.

open access: yesVaccine
Anwari P   +10 more
europepmc   +1 more source

Drug‐induced liver injury associated with selective androgen receptor modulators in an adolescent patient

open access: yesJPGN Reports, EarlyView.
ABSTRACT Selective androgenic receptor modulators (SARMs) have similar properties to anabolic steroids but bind to androgen receptors in a tissue‐specific manner. Studies have investigated the benefits of SARMs in promoting bone and muscle growth while limiting the adverse effects of androgenic stimulation of other organs.
David J. Katibian   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy